AMBEV S.A. current report, Q1 FY2024

Business Context and Reporting Period

This Form 6-K filing by AMBEV S.A. is a Material Fact Notice dated February 29, 2024. The report provides a forward-looking projection for the full fiscal year 2024 regarding the company's beer business operations in Brazil.

Key Financial Metrics

The filing does not report historical revenue, profit, cash flow, or debt figures for the period ended March 31, 2024. Instead, it focuses on a specific cost projection:

  • Cash COGS per hectoliter (Brazil Beer Business): Projected to decrease between 0.5% and 3.0% for the full year 2024.
  • Assumptions: The projection excludes the sale of non-Ambev products on the marketplace and assumes current commodity and foreign exchange (FX) prices.

Material Changes

The filing does not provide comparative data against prior periods. It solely announces a management expectation of cost reduction driven by favorable commodity and FX trends.

Guidance, Outlook, and Risks

Management Commentary: The projected decrease in Cash COGS is attributed to commodities and FX tailwinds. The Chief Financial and Investor Relations Officer, Lucas Machado Lira, signed the notice.

Risks and Contingencies:

  • The projection is not a promise of performance and reflects only management's perception.
  • Results are subject to risks and uncertainties, including general economic, market, and industry conditions beyond management's control.
  • Changes in assumptions could cause actual results to differ from projections.
  • The 2024 information is preliminary and has not yet been reviewed by external auditors.

Investor Verification Checklist

  • Verify the actual commodity and FX price movements throughout 2024 to assess the validity of the cost reduction assumptions.
  • Review the annual financial information for the fiscal year ended December 31, 2023, referenced in the filing for historical context.
  • Monitor future earnings releases for updates on whether the preliminary 2024 projections have been audited or revised.
  • Confirm the impact of non-Ambev product sales on the marketplace, as these are excluded from the current projection.